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In many European Union (EU) Member States (MS),
rare disease (RD) patients are subject to marginalisation
in classic healthcare systems designed for non-rare dis-
eases. As a result they do not experience equal access to
timely, high quality health services they deserve. The
restructuring of healthcare systems to better reflect the
values of equity and solidarity amongst RD patients,
professionals, and policy makers across Europe can be
accomplished through the establishment of Centres of
Expertise (CoE).
Although no official definition of CoE exists, some MS
have established physical expert structures for the man-
agement and care of RD patients at the national level.
Specialising in a single RD or a group of RDs, CoE are
ideally care centres that bring together a group of multi-
disciplinary, specialised competencies and ensure timely
diagnosis and appropriate follow-up care by aiming to
improve the continuity and coordination of care through
the implementation of healthcare pathways.
In addition to providing an added value to the quality
of local healthcare services, CoE are also key determi-
nants for research on rare diseases, and support the
optimisation of healthcare spending in the current eco-
nomic climate. Stakeholders across Europe in the rare
disease community have worked together to establish
several key policy elements synthesized in the Eurordis
Policy Factsheet on CoE.
In order to best establish, manage, and sustain long-
term functioning of CoE, monitoring systems must be
established appropriate for each disease and national
context. Building on the previous work of many stake-
holders in this discussion, MS across Europe should
work toward the establishment of CoE as possibly the
most crucial elements in the context of national plans
and strategies. Although much success has been
observed in the establishment of CoE in several MS,
several challenges for future national strategies on CoE
remain and are identified here.
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